ClinicalTrials.gg
RecruitingNCT05924581Updated May 10, 2024

Validation of Clinical Assessment of Spinal Stiffness

An interventional study of Clinical assessment of spinal stiffness in Hyperkyphosis and Adolescent Idiopathic Scoliosis, sponsored by Istituto Scientifico Italiano Colonna Vertebrale. Recruiting at 1 site in Italy. Open to participants aged 10 Years to 17 Years. Per ClinicalTrials.gov, last updated 2024-05-10.

Sponsored by Istituto Scientifico Italiano Colonna Vertebrale · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
  • Started Jun 2023; still recruiting 3 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
10 Years to 17 Years
Sex
All
01

Study summary

This study aims to validate and verify the reliability of the clinical measures used in the daily routine by doctors and therapists that allow assessing the spinal stiffness in all spatial planes. The secondary objective is the verification of the diagnostic accuracy of the most reliable tests in identifying the subjects at risk of failure, using as a radiographic standard the examinations performed by the patients during the treatment (data retrieved retrospectively) using as a control group those patients who did not obtain a correction of the spine curvature.

02

Conditions studied

  • Hyperkyphosis
  • Adolescent Idiopathic Scoliosis

Browse trials for

03

In context

Kyphosis

132 studies on the registry are indexed under Kyphosis; 31 are open to participants now.

This study's planned enrollment of 25 is below the median of 44 across 82 interventional studies indexed under Kyphosis.

Browse Kyphosis studies →

Lead sponsor

Istituto Scientifico Italiano Colonna Vertebrale is the lead sponsor of 13 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Scoliosis > 10°Cobb or Hyperkyophosis >50° Cobb
  • Age between 10 and 17 years old
  • Risser between 0 and 5

Exclusion criteria

Exclusion Criteria:

  • History of spinal surgery
  • Presence of back pain
  • Diagnosis of congenital scoliosis or scoliosis secondary to neurological or muscular diseases
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    Clinical assessment of spinal stiffness

    Patients' back flexibility will be assessed during the medical examination or physiotherapy session through one of the following non-invasive tests: * Thoracic Stiffness Test (TST) * Scoliosis stiffness test (SST) * Kyphosis Stiffness Test (KST) Each test will be carried out at the beginning of the visit and repeated at the end 2 times by different operators, or once by the same operator to verify that the measurements taken at different times are reliable and that the measurements taken by two different operators are reliable.

    Other: Clinical assessment of spinal stiffness

Interventions

  • OtherClinical assessment of spinal stiffness

    The clinical stiffness tests will be applied twice to the same patient by the same operator to verify intra-operator variability and twice by two operators at the same time to verify inter-operator variability. The verification of diagnostic accuracy with respect to the radiographic reference standard will be carried out retrospectively by using the data already available and systematically collected in electronic format during medical visits and physiotherapy sessions.

06

What researchers measure

Primary outcomes

  1. Reliability

    Test-retest reliability of the three stiffness assessment tests. Inter class correlation will be calculated

    Time frame: through study completion, an average of 6 months

  2. Repeatability

    Inter-Rater and Intra-Rater Repeatability of the three stiffness assessment tests

    Time frame: through study completion, an average of 6 months

  3. Diagnostic accuracy

    diagnostic sensitivity and specificity of each test

    Time frame: through study completion, an average of 6 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Anonymised data will be deposited in an online repository

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2023 (actual). Primary completion is estimated for Dec 2024, 18 months after the start.

Of 56 non-industry interventional studies with no phase under Kyphosis, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 30. This study's planned 18 months is above that.

Counting every sponsor, half of 58 studies reached it within 9 months; a quarter within 4 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 15, 2023
First posted
Jun 29, 2023
StartActual
Jun 6, 2023
Primary completionEst.
Dec 2024
CompletionEst.
Dec 2024
Last update
May 10, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 10, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05924581
Lead sponsor
Istituto Scientifico Italiano Colonna Vertebrale
Responsible party
Sponsor
First posted
Jun 29, 2023
Start date
Jun 6, 2023
Primary completion
Dec 2024 (estimated)
Completion
Dec 2024 (estimated)
Last update
May 10, 2024

Study contacts

Stefano Negrini, MD, PhD
Contact
stefano.negrini@isico.it
+3902 8416 1700
Alessandra Negrini
Contact
alessandra.negrini@isico.it
+3902 8416 1700

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion